Healthy high growth potential

Results

1488

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1488 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MIDWESTLTD
₹1,289.80-0.02%n/a₹46.6b₹1,500.0044.559.3%n/aMaterials
VIKRAMSOLR
₹185.28-7.6%n/a₹67.1b₹246.6014.330.0%n/aSemiconductors
APOLLO
₹384.40-11.3%99.4%₹144.5b₹382.50128.041.3%0.06%Capital Goods
501423
₹2,849.801.8%67.9%₹131.0b₹3,517.6777.133.7%0.1%Capital Goods
SCHNEIDER
₹1,335.300.3%68.4%₹319.3b₹1,230.00150.234.0%n/aCapital Goods
EIEL
₹218.556.2%-8.1%₹38.4b₹346.0021.037.8%n/aCapital Goods
SAATVIKGL
₹475.35-0.4%n/a₹60.4b₹520.0016.948.8%n/aSemiconductors
AGP
€7.000.6%-9.4%€127.6m€8.5725.737.8%n/aCapital Goods
MONOLITH
₹750.856.1%172.4%₹16.3b₹960.0070.937.2%n/aMaterials
543273
₹2,240.508.0%176.0%₹54.8b₹2,500.0069.553.9%n/aTransportation
AXSM
US$241.67-3.5%133.8%US$12.2bUS$276.4717.657.4%n/aPharmaceuticals & Biotech
FWRY
ج.م18.70-1.1%47.8%ج.م63.7bج.م21.2423.928.7%n/aDiversified Financials
CDR
zł217.40-3.0%-21.0%zł21.7bzł235.3842.127.1%0.5%Media
MDGL
US$512.651.4%70.5%US$11.8bUS$678.7110.459.2%n/aPharmaceuticals & Biotech
MOD
US$255.99-13.9%152.6%US$15.0bUS$340.86111.349.3%n/aCapital Goods
CORT
US$87.329.3%19.3%US$9.1bUS$88.00200.848.9%n/aPharmaceuticals & Biotech
RHM
€946.60-21.3%-45.9%€44.1b€1,798.6042.030.6%1.2%Capital Goods
LITE
US$816.98-3.9%762.2%US$67.1bUS$1,111.29144.879.1%n/aTech
CRDO
US$238.00-12.4%154.6%US$50.0bUS$269.8194.027.5%n/aSemiconductors
KEBNI B
SEK 1.20-5.0%-41.6%SEK 329.9mSEK 1.602.982.7%n/aTech
NVDA
US$192.53-8.6%22.0%US$4.7tUS$300.5929.221.8%0.5%Semiconductors
2455
NT$348.00-16.3%167.7%NT$64.3bNT$398.50109.945.2%0.8%Semiconductors
2480
HK$12.810.5%-46.6%HK$2.5bHK$31.003.377.1%n/aPharmaceuticals & Biotech
2315
HK$40.50-1.1%78.8%HK$40.2bHK$62.0254.040.4%n/aPharmaceuticals & Biotech
Page 1 of 42